Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ivicentamab (GEN-3009), an IgG1κ humanized monoclonal antibody targeting CD37, is utilized in cancer research [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | Inquiry | Inquiry | |
5 mg | Inquiry | Inquiry |
Description | Ivicentamab (GEN-3009), an IgG1κ humanized monoclonal antibody targeting CD37, is utilized in cancer research [1]. |
Synonyms | GEN-3009 |
Molecular Weight | N/A |
CAS No. | 2364496-42-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ivicentamab 2364496-42-2 GEN-3009 inhibitor inhibit